Another mega pharma deal! Cipla to buy Hyderabad-based Hetero Drugs for $550mn
Advertisement
Advertisement
Cipla is all set to expand its portfolio. And this includes buying of the American business of Hyderabad-based Hetero Drugs. Country’s third-largest drug maker will buy Invagen and Camber, Hetero's wholly owned subsidiary, for about $550 million.Cipla's efforts to expand its beachhead in the US suffered a setback recently after it lost out to Lannett in the race to buy Kremers Urban, the generics business of Belgian drugmaker UCB.
While the spokesperson of Hetero stayed quite on the issue, he did say, "As a pharmaceutical company, we are constantly in discussions with multiple parties on potential collaboration opportunities - in line with our aspiration to drive access and ensure availability of high-quality, affordable medicines."
As Indian rivals of Cipla are quite present in the US, it didn’t want to lose out on opportunities. Dr YK Hamied founded company was holding talks on the plan since a year.
With the Invagen and Camber purchase, Cipla will also get access to a manufacturing facility and approvals to treat a variety of illnesses - from HIV, hypertension and heart diseases to depression drugs such as acyclovir, amlodipine, escitalopram. Hetero received a boost recently when it secured the approval to make aripiprazole, a blockbuster drug used to treat schizophrenia and bipolar disorder.
Advertisement
Advertisement
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Saudi Arabia wants China to help fund its struggling $500 billion Neom megaproject. Investors may not be too excited.
- Catan adds climate change to the latest edition of the world-famous board game
- Tired of blatant misinformation in the media? This video game can help you and your family fight fake news!
- Tired of blatant misinformation in the media? This video game can help you and your family fight fake news!
- JNK India IPO allotment – How to check allotment, GMP, listing date and more
- Indian Army unveils selfie point at Hombotingla Pass ahead of 25th anniversary of Kargil Vijay Diwas
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market